Dr. Mark L Vinick, DC, CAS Logo

Fibromyalgia Relief with Chiropractic

Redondo Beach natural fibromyalgia treatmentIf you are struggling with fibromyalgia, you are not alone, as Dr. Vinick sees many patients with this particular problem in our Redondo Beach chiropractic office. As a matter of fact, the Centers for Disease Control and Prevention (CDC) estimates that roughly two percent of all adults in the United States have fibromyalgia. Thankfully, chiropractic is one treatment option that can provide positive results.

In a medical study published in mid-2015, 215 adults with fibromyalgia were evaluated based on factors ranging from pain to quality of sleep to the levels of depression symptoms and anxiety they felt. Then they were divided into two groups with one group receiving a multi-modal treatment program for three months and the second group receiving the same approach plus chiropractic adjustments (specifically, to the upper neck tissues) for the same length of time.

The subjects who received chiropractic adjustments combined with the multi-disciplinary treatment program reported greater results in all areas (pain, sleep, depression, and anxiety) at three months post-treatment when compared to the study patients who received multi-modal treatment without chiropractic care. In addition, those positive results were long-lasting as the individuals reported continued improvement one full year later.

Fibromyalgia can substantially decrease your quality of life, both psychologically and physically. If you're struggling with fibromyalgia, we might be able to help.

You don't have to suffer! To see what Dr. Vinick can do for your fibromyalgia, call our Redondo Beach chiropractic office today.

Studies

  • Fibromyalgia. Centers for Disease Control and Prevention. Retrieved from http://www.cdc.gov/arthritis/basics/fibromyalgia.htm on November 2, 2015.
  • Moustafa I & Diab A. (2015, July). The addition of upper cervical manipulative therapy in the treatment of patients with fibromyalgia: a randomized controlled trial. Rheumatology International;35(7):1163-74.
December 05, 2016
Tweet